Research
Hormonal
Blood concentration of adiponectin is reduced in obesity and type 2 diabetes.
Monitoring adiponectin levels may provide insights into metabolic health in patients.
WeakSupportsmedium confidence
Adiponectin is an insulin-sensitizing hormone whose blood concentration is reduced in obesity and type 2 diabetes.
Why this rating
The statement is based on established knowledge rather than new experimental data.
Source
The Insulin-sensitizing Role of the Fat Derived Hormone Adiponectin
Leonie K. Heilbronn et al. · Current Pharmaceutical Design · 2003
DOI 10.2174/1381612033454766
otherCited 69×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →